Malignant gastrointestinal stromal tumours treated with imatinib in France: results in unselected patients

被引：0
|
作者：
Bouche, O. [1 ]
Cioffi, A. [2 ]
Rios, M. [3 ]
Blesius, A. [4 ]
Chaigneau, L. [5 ]
Ray-Coquard, I. [6 ]
Blay, J. Y.
Le Cesne, A. [2 ]
Bisot-Locard, S.
Deschaseaux, C. [7 ]
机构：
[1] CHU Reims, Serv Hepatogastroenterol & Cancerol Digest, Reims, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France
[4] Hop Enfants La Timone, Marseille, France
[5] Hop Jean Minjoz, F-25030 Besancon, France
[6] Ctr Leon Berard, Dept Oncol Med Adulte, F-69373 Lyon, France
[7] Novartis Pharmaceut, Market Access, Rueil Malmaison, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)72003-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：594 / 594
页数：1
相关论文
共 50 条
  • [1] MALIGNANT GASTROINTESTINAL STROMAL TUMORS TREATED WITH IMATINIB IN FRANCE: EFFICACY IN REAL LIFE
    Blay, J. Y.
    Bouche, O.
    Cucherat, M.
    Goldberg, M.
    Grosclaude, P.
    Sambuc, R.
    Bisot-Locard, S.
    Deschaseaux, C.
    Sailly, J.
    VALUE IN HEALTH, 2009, 12 (07) : A257 - A258
  • [2] Therapeutic imatinib monitoring in patients with gastrointestinal stromal tumours.
    Spiliopoulou, Pavlina
    Currie, Dawn
    Haig, Caroline
    Cowie, Fiona
    White, Jeff D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Therapeutic drug monitoring of imatinib in patients with gastrointestinal stromal tumours - Results from daily clinical
    IJzerman, Nikki S.
    Groenland, Stefanie L.
    Koenen, Anne Miek
    Kerst, Martijn
    van der Graaf, Winette T. A.
    Rosing, Hilde
    Beijnen, Jos H.
    Huitema, Alwin D. R.
    Steeghs, Neeltje
    EUROPEAN JOURNAL OF CANCER, 2020, 136 : 140 - 148
  • [4] Treatment of gastrointestinal stromal tumours: imatinib, sunitinib - and then?
    Nilsson, Bengt
    Nilsson, Ola
    Ahlman, Hakan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (04) : 457 - 468
  • [5] Imatinib MesylateIn the Treatment of Gastrointestinal Stromal Tumours
    Katherine F. Croom
    Caroline M. Perry
    Drugs, 2003, 63 : 513 - 522
  • [6] Imatinib mesylate - In the treatment of gastrointestinal stromal tumours
    Croom, KF
    Perry, CM
    DRUGS, 2003, 63 (05) : 513 - 522
  • [7] Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
    Fauske, Lena
    Waerstad, Pernille H.
    Hompland, Ivar
    Bruland, Oyvind S.
    ANTICANCER RESEARCH, 2022, 42 (02) : 955 - 963
  • [8] Management of malignant gastrointestinal stromal tumours
    Joensuu, H
    Fletcher, C
    Dimitrijevic, S
    Silberman, S
    Roberts, P
    Demetri, G
    LANCET ONCOLOGY, 2002, 3 (11): : 655 - 664
  • [9] Reversible sarcopenia in patients with gastrointestinal stromal tumor treated with imatinib
    Moryoussef, Frederick
    Dhooge, Marion
    Volet, Julien
    Barbe, Coralie
    Brezault, Catherine
    Hoeffel, Christine
    Coriat, Romain
    Bouche, Olivier
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (04) : 343 - 350
  • [10] Imatinib mesylate in the management of gastrointestinal stromal tumours (GIST)
    Kurteva G.P.
    Kurtev P.F.
    memo - Magazine of European Medical Oncology, 2010, 3 (2) : 49 - 52
12345